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pituitary Metastasis: Lung Cancer Presenting as Bitemporal
hemianopsia with Diabetes Insipidus and Anterior Pituitary Deficiency
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4. Keith Cryar, MD,* Jay Morgan, MD,t Jack P. Rock, MD,^ and Max Wisgerhof, MD*

I
Symptoms and signs ofpituitary disease are rarely the first manifestations of malignancy originating
in another organ. We present a case which exemplifies the key points that suggest a diagnosis of
metastatic pituitary disease. Our patient's diagnosis wds adenocarcinoma ofthe lung with a
metastasis to the intrasellar and suprasellar regions, which caused diabetes insipidus, anterior
pituitary deficiency, arui visualfielddefects. The metastasis had a dumbbell appearance and extended
from the sella turcica into the suprasellar region. Diabetes insipidus was the initial clinical
manifestation of lung cancer in this patient. A metastasis to the pituitary should be suspected if
diabetes insipidus is the initial manifestation ofan intrasellar mass. (Henry Ford Hosp Med J
1987:35:185-7)

etastatic pituitary disease is rarely recognized clinically.
Even when clinical suspicion is high, as in patients known
to have cancer, tumor metastatic to the pituitary is usually recognized only at autopsy (1,2). Nevertheless, symptoms or signs of
pituitary disease can be the first manifestation of malignancy
originating in another organ (3-5). Such a case is presented,
which exemplifies the key points that suggest a diagnosis of metastatic disease in the pituitary.

M

Case Report
A 62-year-old man presented with a chief complaint of peripheral
vision loss occurring over several days. He had had several weeks of
mild, intermittent diplopia, but he did not seek medical care until the
loss of peripheral vision began to interfere with his golf game.
On questioning, he revealed that six months ago his usual nocturia
had increased to six to eighttimesper night with daytime polyuria and
polydipsia of about two gallons of liquids per day. He had lost 20
pounds over the last six months, and for four months he had experienced fatigue, constipation, intolerance of the cold, dryness ofthe skin
and hair, altered sense of taste, anosmia, and impaired mentation. Leftsided occipital headaches enduring several hours had been present
mornings for the last two months. A two-year history of decreased
libido had recently progressed to complete loss of libido with hot
Hushes and impotence.
His history was remarkable for a 35 pack/year habit of cigarette
smoking. He had stopped smoking five years ago when chronic
obstructive pulmonary disease with bronchospasm was diagnosed. One
year ago, daily prednisone treatment was added to the other treatments
forthis disease.
Physical examination showed him to be well developed, well nour'^lied, and in no acute distress. His vital signs were normal. His hair was
""e. dry, and normally distributed. There was bilateral papilledema and
•I'plopia on upward gaze. Goldmann visual field testing showed bilattemporal field defects (right greater than left). His lungfieldswere
clear with a prolonged expiratory phase, and no abnormal cardiac or

abdominal signs were present. Lymphadenopathy was not present. The
relaxation phase was delayed in the deep tendon reflexes, and the testicles were soft.
His complete blood count and automated chemistry profile were normal , except for a semm sodium of 145 mmol/L. The urine specific gravity was 1.004, and the urine osmolality was 220 mosm/kg. The serum
thyroxine was 4.9 p-g/dL, thyroid-stimulating hormone 1.2 |jirU/mL,
testosterone < 20 ng/dL, luteinizing hormone < 2.5 p,rU/mL, and prolactin 19 ng/mL. Cortisol was not measured because of the chronic
treatment with prednisone. Chest roentgenogram revealed a 4.0 cm
opacity in the superior segment of the lingula, enlargement of the root
of the left lung, and thickening of the softtissuesin the right paratracheal region. Thesefindingssuggested the presence of lung cancer in
the lingula with metastases to the lung root and the right paratracheal
area. Cranial computed tomography showed an enlarged sella turcica
containing a dumbbell-shaped, enhancing mass extending into the
suprasellar region to the foramen of Monro and compressing the optic
chiasm (Figure).
A presumptive diagnosis was made of primary lung cancer with metastasis to the sellar and suprasellar regions causing diabetes insipidus,
hypothalamic dysfunction, anterior pituitary deficiency, and visual
field defects. He was treated with replacement therapy of DDAVP,
thyroxine, and testosterone. Prednisone was continued. Bronchoscopic
biopsy was positive for well-differentiated adenocarcinoma ofthe
lung. He underwent frontal craniotomy to relieve the visual field defects, and histological examination of the pituitary mass revealed ade-
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Figure—Cranial computed tomography showing a dumbbellshaped, enhancing mass (arrows) in the sella extending into the
suprasellar region.
nocarcinoma, similar to the lung neoplasm. Postoperatively, Goldmann
visualfieldsshowed resolution of the temporal field defects. He was
subsequentiy treated with chemotherapy and whole brain radiation.

Discussion
Interest in this case stems from the presentation of a symptomatic sellar mass as the initial manifestation of a previously
unrecognized lung cancer The autopsy incidence of metastatic
pituitary disease varies depending on the series cited. Reports
from unselected autopsies document as little as 0.14% to 1.0%
involvement, while autopsy series on cancer patients have demonstrated up to a 28% incidence (1,2). Cancer of almost every
type has been described as a source of metastases to the pituitary
(6). Among the solid tumors, breast and lung cancer predominate. Metastases from lung cancer account for up to 60% of
pituitary metastases among men (1,4,6), and breast cancer metastases account for up to 70% of pituitary metastases among
women (4).
There is a predilection for pituitary metastases to occur in the
neurohypophysis (1,3,5,7). A review of the literature by Max et
al (3) revealed that of 178 reported cases of pituitary metastases,
the neurohypophysis was involved alone in 52% and the adenohypophysis was involved alone in only 21%. The reason for
this discrepancy in presentation is thought to be inherent in the
blood supply to the pituitary gland. Arterial blood is supplied
directly to the neurohypophysis by the inferior hypophyseal
arteries. The blood supply to the anterior pituitary is predominantly postcapillary blood from the hypothalamus via the long
portal veins. This would suggest that the higher frequency of
metastases to the posterior pituitary than to the anterior pituitary
is due to the predominantly portal (postcapillary) type of blood
supply to the anterior pituitary. Supporting evidence for this hypothesis is provided by Goldman and Sapirstein's studies (8) in
which radioactive microspheres injected into the carotid arteries
of rats localized in the neurohypophysis and hypothalamus, and
not in the adenohypophysis.
The anterior pituitary is involved in up to 67% of the cases of
pituitary metastases evaluated at autopsy, but anterior pituitary
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dysfunction is rare (1,3,4). In reviewing 28 previously reported
jisseminati
cases of symptomatic pituitary metastases in which sufficiem employed.
endocrinological data were available. Max et al (3) found that
In conclu
only three of the patients had anterior pituitary deficiency. In % i of maligna
of 88 cases of pituitary metastases, Teears and Silverman (4) ! When clini<
found discrete anterior pituitary infarcts which were postulated
sipidus. Syi
to have occurred secondary to neurohypophyseal involvement
hypothalan
with metastatic disease compromising the blood supply to the may present
adenohypophysis. None of the infarcts resulted in anterior pituj. ofmalignan
tary dysfunction. The low frequency of anterior pituitary dys- insipidus or
function in pituitary metastasis may be best explained by the fact insipidus sl
that a large portion of the anterior pituitary must be destroyed
pitoitary. A]
before clinical hypopituitarism is evident (1,9,10).
ally irradiati
The majority of cases of pituitary metastases recognized ante- onstration (
primary tun
mortem have diabetes insipidus (3). The presence of diabetes
insipidus early in the course of metastasis to the pituitary is illustrated in Kimmel and O'Neill's series (6). In 11 of 25 patients,
diabetes insipidus as a complication of metastatic disease was
the initial symptom of the malignancy. That diabetes insipidus is
a clue to the presence of metastasis is also shown by the same
report. In 100 consecutive cases of diabetes insipidus at Mayo
Clinic, 14% were secondary to metastatic disease, 27% were
secondary to trauma, and 25% were idiopathic (6). Most cases
of pituitary metastases are asymptomatic, however Teears and
Silverman (4) found that only 7% of 88 patients with pituitary
metastases had diabetes insipidus.
Because of the origin of antidiuretic hormone in the supraoptic and paraventricular nuclei, hypothalamic dysfunction
must be present in patients with persistent diabetes insipidus. In
our patient, symptoms of impaired smell, taste, libido, and
mentation were present in addition to diabetes insipidus. These
symptoms indicate effects of the metastasis beyond its immediate sellar-suprasellar location.
The most common cause of an intrasellar mass is a pituitary
adenoma in patients with or without malignancy (3). Adenomas
usually manifest with anterior pituitary dysfunction or visual
field defects (3). Diabetes insipidus is typically a late finding
(11). In metastatic disease to the pituitary, diabetes insipidus is
usually the first noted abnormality of pituitary function with anterior pituitary deficiency occurring after the onset of diabetes
insipidus (3,4), as in the present case.
Treatment of an intrasellar mass in cancer patients depends
upon the clinical picture. If it is that of a benign mass and
survival with the cancer is expected to be six or more months,
treatment should be the same as for patients without cancer. If.
however, the clinical picture is that of a pituitary metastasis,
treatment should be irradiation to the pituitary. Surgical intet'
vention would be indicated if the discovery of metastasis wou'
influence therapy of the primary cancer or if surgery would I*
sight-saving.
If surgical intervention is indicated, the transfrontalorth'
transsphenoidal route may be used for tissue diagnosis and op"
apparatus decompression. Although in our patient the dumD"^
shape of the lesion might not have lent itself to thorough
compression through the sphenoid, either method can be
tive in decompressing the optic apparatus. The transspheno'
route is safer, easier for the patient to tolerate, and has the tc
oretical advantage of not opening the intracranial space to tum
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dissemination, as may be the case if transfrontal craniotomy is
employedIn conclusion, pituitary metastasis is a frequent complication
of malignancy but is infrequently recognized antemortem.
^ e n clinically evident, it will likely present as diabetes insipidus. Symptoms or signs of anterior pituitary deficiency and
[,ypothalamic dysfunction may subsequently occur. Patients
0ay present with pituitary metastasis as the initial manifestation
of malignancy. An intrasellar mass which presents with diabetes
Insipidus or anterior pituitary deficiency preceded by diabetes
insipidus should suggest the presence of a metastasis to the
pituitary. Appropriate treatment of a pituitary metastasis is usually irradiation. Surgical treatment is indicated if definite demgnstration of metastatic disease would affect therapy of the
primary tumor or if surgery would be sight-saving.
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